On Aug 03, 2026, MED reported earnings of -0.28 USD per share (EPS) for Q2 26, beating the estimate of -0.65 USD, resulting in a 57.35% surprise. Revenue reached 76.38 million, compared to an expected 73.43 million, with a 4.03% difference. The market reacted with a +34.29% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 2 analysts forecast an EPS of -0.62 USD, with revenue projected to reach 72.01 million USD, implying an increase of 121.43% EPS, and decrease of -5.72% in Revenue from the last quarter.